The dynamic interplay between the extracellular matrix and embryonic stem cells (ESCs) constitutes one of the key steps in understanding stem cell differentiation in vitro. Here we report a biologically-active laminin-111 fragment generated by matrix metalloproteinase 2 (MMP2) processing, which is highly up-regulated during differentiation. We show that the β1-chain-derived fragment interacts via α3β1-integrins, thereby triggering the down-regulation of MMP2 in mouse and human ESCs. Additionally, the expression of MMP9 and E-cadherin is up-regulated in mouse ESCs-key players in the epithelial-to-mesenchymal transition. We also demonstrate that the fragment acts through the α3β1-integrin/extracellular matrix metalloproteinase inducer complex. This study reveals a previously unidentified role of laminin-111 in early stem cell differentiation that goes far beyond basement membrane assembly and a mechanism by which an MMP2-cleaved laminin fragment regulates the expression of E-cadherin, MMP2, and MMP9. L aminin-111, together with laminin-511, is among the first extracellular matrix (ECM) proteins expressed during early embryogenesis. Members of the laminin family are highly conserved between different species and are critical constituents of basement membranes in the early blastocyst as well as a variety of other tissues (1). The expression of the three laminin-111 chains-α1, β1, and γ1-is initiated as early as at the two-cell stage (2-4). Laminin-111-together with collagen IV, nidogen, perlecan, and other proteins-is assembled into the basement membrane (5), where it provides not only physical support, but also the capacity to modulate ECM function when modified by other proteins (6-8).
The dynamic interplay between the extracellular matrix and embryonic stem cells (ESCs) constitutes one of the key steps in understanding stem cell differentiation in vitro. Here we report a biologically-active laminin-111 fragment generated by matrix metalloproteinase 2 (MMP2) processing, which is highly up-regulated during differentiation. We show that the β1-chain-derived fragment interacts via α3β1-integrins, thereby triggering the down-regulation of MMP2 in mouse and human ESCs. Additionally, the expression of MMP9 and E-cadherin is up-regulated in mouse ESCs-key players in the epithelial-to-mesenchymal transition. We also demonstrate that the fragment acts through the α3β1-integrin/extracellular matrix metalloproteinase inducer complex. This study reveals a previously unidentified role of laminin-111 in early stem cell differentiation that goes far beyond basement membrane assembly and a mechanism by which an MMP2-cleaved laminin fragment regulates the expression of E-cadherin, MMP2, and MMP9. L aminin-111, together with laminin-511, is among the first extracellular matrix (ECM) proteins expressed during early embryogenesis. Members of the laminin family are highly conserved between different species and are critical constituents of basement membranes in the early blastocyst as well as a variety of other tissues (1) . The expression of the three laminin-111 chains-α1, β1, and γ1-is initiated as early as at the two-cell stage (2) (3) (4) . Laminin-111-together with collagen IV, nidogen, perlecan, and other proteins-is assembled into the basement membrane (5) , where it provides not only physical support, but also the capacity to modulate ECM function when modified by other proteins (6) (7) (8) .
The interactions between matrix metalloproteinases (MMPs) and ECM proteins have been extensively studied over the past decades (9, 10) . The cellular expression of MMPs is precisely regulated such that ECM molecules are processed at different cell stages (11) . It has been shown that laminin-111 can be processed by different MMPs and a variety of other enzymes and that such modifications are mainly related to cell migration because cleavage of laminin results in a loosened basement membrane (6, 8, 12, 13) . Recent insights into the existence of "cryptic" ECM interaction sites-sequences usually hidden within the tertiary structure of the protein or within the assembly of the ECM-have enabled a greater understanding of how cells interact with the ECM and of the astonishingly complex interaction between cells and ECM proteins (14) . The ECM can no longer be thought of as just a passive scaffold and physical support for cells in vivo or as a more-or-less adequate cell culture substrate in vitro; the ECM and its modification is now known to act as one of the key constituents in cell regulation. Therefore, to successfully model development in vitro by using pluripotent stem cells, it is imperative to give careful consideration to cell-ECM interactions.
In this work, we address the question of whether MMP2 (15-17) modifies laminin-111 and whether such modifications act to regulate cell behavior such as the epithelial-to-mesenchymal transition (EMT). The EMT is an essential process in a variety of different cellular changes such as phenotype and migratory capacity, but, most importantly, it is fundamental for early embryonic development. During the EMT, cells that are initially attached to each other by tight cell-cell junctions and to the basement membrane via their basal surface (epithelial-type), start to detach and migrate out of the dense cellular layer and adapt a mesenchymal phenotype (18, 19) . As the embryo develops, the EMT is regulated by an extensive cross-talk of different regulatory signaling pathways and cellular changes, leading to common endpoints such as cadherin switching, MMP2 and MMP9 up-regulation, snai1 and snai2 up-regulation, accumulation of β-catenin in the nucleus leading to Wnt signaling activation, and up-regulation of twist and vimentin (20) (21) (22) (23) (24) . Interactions with the ECM as well as secreted soluble growth factors play a role in the regulation of the EMT, and integrin signaling feeds into EMT-regulating pathways (25, 26 )-e.g., the exposition of cryptic sites in fibronectin due to mechanical strain and subsequent integrin binding triggers changes in the EMT (27, 28) . Although much attention has been dedicated to understanding the mechanism of the EMT, there are many open questions concerning the roles of certain ECM proteins in the EMT signaling cascade. In this work, we have identified a biologicallyactive laminin-111 fragment, derived from MMP2 cleavage of the β1-chain, which modulates pluripotent stem cell behavior and EMT signals through the α3β1-integrin/ECM metalloproteinase inducer (EMMPRIN) complex. These findings reveal a previously unidentified mechanism in the important interplay between a cryptic site of laminin-111 and the EMT in early differentiation.
Significance
Laminin-111 is one of the first extracellular matrix proteins expressed during embryogenesis and has been studied for decades, mainly because of its major role in assembling the basement membrane, but also because it has now become one of the most popular cell culture substrates for embryonic stem cells. However, considering the importance of this protein, the role laminin-111 plays during matrix remodeling-which is not only of great interest when seeking to understand cell-matrix interactions, but also when using laminin as a substrate for tissue engineering-is still unclear. Our findings propose a previously unidentified role of laminin-111 that goes beyond basement membrane assembly and an important involvement in the regulation of the epithelial-to-mesenchymal transition.
Results

MMP2
Cleaves the β1-Chain of Laminin-111. Remodeling of the ECM to facilitate pluripotent cell migration is highly dependent on the expression of MMPs. It is assumed that there is developmental regulation of MMP expression, and it has been suggested that only a few MMPs are actually expressed during the early stages of preimplantation development (29, 30 ). Here we started by investigating the expression profile of MMP2, one of the main extracellular enzymes enabling embryonic implantation (15) (16) (17) . Fig. 1 shows the time-dependent expression and activity of MMP2 in mouse ( Fig. 1 A and B) and human ( Fig. 1 C  and D ) embryonic stem cells (ESCs) during differentiation into embryoid bodies (EBs) for 5 and 14 d, respectively. Only negligible amounts of MMP2 are present at the pluripotent stage, whereas MMP2 expression and activity is significantly up-regulated during the first days of spontaneous EB differentiation. To elucidate how MMP2 processes laminin-111, mouse laminin-111 was incubated with active MMP2, and the resulting protein fragments were analyzed by gel electrophoresis. We observed a distinct band at ∼60 kDa corresponding to a unique fragment released by MMP2 on both the native (Fig. 1 E, lane 3) and denaturing ( Fig. 1 E, lane 5) gels. Subsequent digestion of the 60-kDa band and nano-liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) analysis of the resulting peptides identified the fragment as derived from the N terminus of the β1-chain of laminin-111 (Fig. S1 ). The peptides were searched against a protein database containing all laminin chains, and the best match and sequence coverage was obtained with the β1-chain. The N-terminal region of the β1-chain (β1-LN-LE1-4) is composed of one LN (laminin N-terminal) domain and four LE (laminin-type epidermal growth factor-like) domains (Fig. 1F) . The N-terminal regions of the three short arms of laminin-111 are responsible for the formation of the laminin network (31) and have the same domain architecture, but the sequence identity between the short arms of the α1-, β1-, and γ1-chains is only ∼30%. MMP2 cleavage of the short arm of the β1-chain is predicted to disassemble the laminin network. Indeed, degradation of laminin-111 coatings on tissue culture plastic was observed after 3 h of MMP2 treatment by immunofluorescence, with complete removal after 12 h (Fig. 1G ). This observation was confirmed by immunogold staining of laminin-111 before and after treatment with MMP2 (Fig. 1H ). These results indicate that the up-regulation of MMP2 during differentiation leads to the degradation of laminin-111 and therefore the basement membrane. The resulting β1-LN-LE1-4 fragment can be recombinantly produced as a stable protein (32) , indicating that it can either be released as a soluble factor or may remain within the ECM through noncovalent or covalent interactions. It has been shown that the release of cryptic sites of ECM proteins can trigger cell responses by revealing new binding sites for receptors previously hidden within the protein tertiary structure (27, 28) . Biologically-active laminin-111 fragments that are able to function as soluble signaling molecules, however, have not yet been reported. Therefore, to investigate whether the cleavage of laminin-111 by MMP2 has further biological consequences beyond the modification of the basement membrane, the response of human and mouse ESCs to the fragment was examined. and on full-length laminin-111. Mouse ESCs adhering to the fragment showed a similar morphology as on full-length laminin-111 and were able to be passaged and kept in a pluripotent state ( Fig. 2 A and B) , whereas human ESCs did not attach to the fragment compared with laminin-111 ( Fig. 2 C and D) . To quantify adhesion and to compare attachment on the two other short arm fragments, α1-LN-LE1-4 and γ1-LN-LE1-4, mouse ESCs were seeded on plates coated with different concentrations of the respective fragments and full-length laminin-111. Although slightly more cells attached to full-length laminin-111 than to the β1-LN-LE1-4 fragment, the concentration-dependent attachment profiles were very similar. In sharp contrast, very few cells attached to the γ1-LN-LE1-4 fragment. As expected, cells also attached to the α1-LN-LE1-4, which is known to contain one or more integrinbinding sites (39) (Fig. 2E) . From these experiments, we therefore conclude that the laminin β1-LN-LE1-4 fragment contains one or more cell receptor-binding sites for mouse ESCs.
To identify the nature of these receptor-ligand interactions, we used antibodies against all integrin subunits that have been reported for adhesion to laminin-111 (38) . Cell attachment to the β1-LN-LE1-4 fragment was reduced by ∼30% using an antibody against β1-integrin subunits, a component of some of the main receptors of pluripotent cells (40) . Attachment was also reduced (∼40%) when the α3-integrin subunit was blocked. When a combination of both blocking antibodies was tested, the greatest reduction of attachment (∼50%) was observed (Fig. 2F) . The blocking of integrin subunits α1, α2, α6, and α7, as well as combinations of these antibodies with the anti-β1-integrin antibody, did not show any reduction in cell attachment, allowing for the assumption that the β1-LN-LE1-4 fragment contains a previously unidentified binding site for α3-and β1-integrin. The α3β1-integrin constitutes one of the main basement membrane receptors and can form complexes with a variety of different ligands, triggering different signaling cascades, and is involved in maintaining cell-cell junctions, assembling the cytoskeleton, facilitating cell migration due to interactions with tetraspanin proteins, and MMP regulation via the EMMPRIN (CD147) protein (25, (41) (42) (43) (44) (45) (46) . Consistent with the presence of α3β1-integrin in a variety of different cell and tissue types, fluorescently labeled β1-LN-LE1-4 fragment was observed to accumulate in various regions of the EBs derived from human and mouse cells (Fig. 2  G and H) , where the quantification of bound β1-LN-LE1-4 fragment was similar in mouse and human EBs (Fig. S2) . The collective data suggest that the β1-LN-LE1-4 fragment has further biological functions resulting from its interaction with α3β1-integrin, where the presence of this integrin is sufficient to provide attachment of mouse ESCs, but not of human ESCs. It has been shown that the attachment of human ESCs to laminin-111 is mainly mediated by α6β1-integrin (36, (47) (48) (49) . Thus, it is not surprising that they attach less to the fragment than to full-length laminin-111 because the β1-LN-LE1-4 fragment does not possess binding sites for α6β1-integrin. However, the binding of the fragment to both mouse and human EBs, as assessed by confocal microscopy ( Fig. 2  G and H) , allows for the assumption that the fragment can interact with both mouse and human differentiated cells.
Laminin β1-LN-LE1-4 Fragment Decreases Expression and Activity of MMP2. MMP2 expression is regulated by different mechanisms inside and outside the cell. Besides regulation on a transcriptional level, MMP2 can be inhibited by tissue inhibitors of metalloproteinases (TIMPs) and activated by other MMPs once exported to the plasma membrane (11, 15) . The effects of the β1-LN-LE1-4 fragment on the expression and activity of MMP2 produced by human and mouse EBs was evaluated (Fig. 3) . When the β1-LN-LE1-4 fragment was added to the mediumhypothesizing that the fragment might be released as a fully soluble fragment by MMP2-a significant down-regulation of MMP2 expression was observed compared with control samples (Fig. 3 A and B) . This effect was specific because it was not observed with the structurally related α1-and γ1-chain fragments (Fig. 3D) . During EB differentiation, MMP2 is usually upregulated as part of the differentiation process, particularly during the EMT, representing the very onset of stem cell differentiation. As part of the EMT, MMPs are up-regulated to enable the cells to move out of the dense surrounding basement membrane and to remodel the ECM. It was observed here that an excess of the β1-LN-LE1-4 fragment triggers a down-regulation of MMP2, which seems to provide a negative-feedback mechanism on MMP2 regulation by the product of MMP2 itself. This down-regulation due to the β1-LN-LE1-4 fragment was matched by a decrease in MMP2 activity in the medium of both mouse and human samples (Fig. 3C ). In addition, differences in the expression of two inhibitors of MMP2, TIMP1 and TIMP2, were observed ( Fig. 3 A and B) . Thus, not only MMP2 expression, but also TIMP regulation, are influenced by the MMP2-cleaved fragment, which allows for the assumption that the β1-LN-LE1-4 fragment actually triggers cell responses and is not only cleaved for the purpose of basement membrane remodeling. Given that MMP2 plays a crucial role during the EMT-and that the β1-LN-LE1-4 fragment specifically downregulates MMP2-the impact of β1-LN-LE1-4 fragment on EMT-related gene expression was tested.
Laminin β1-LN-LE1-4 Fragment Triggers Changes in the Expression of
EMT-Related Genes. One of the key events during the EMT is the detachment of epithelial-type cells triggered by the degradation of the basement membrane (18) . Fig. 1 shows that the upregulation of MMP2 causes such degradation. It has been reported that the revelation of cryptic α3β1-integrin-binding sites in fibronectin-triggered by the stretching of only a few nanometers due to mechanical force-plays a strong EMTinhibitory role (27) . In addition, α3β1-integrins are involved in MMP regulation and are thought to coordinate cross-talk between β-catenin and Smad signaling pathways, thereby regulating responses to TGF-β1 activation (45, 46) . To determine whether the processing of laminin-111 by MMP2 acts beyond providing a negative-feedback mechanism, the expression of the most prominent EMT-related genes was monitored in the presence of the β1-LN-LE1-4 fragment. We examined EMT gene expression, both with the medium supplemented with β1-LN-LE1-4 fragment (i.e., assuming that the fragment acts as a soluble factor) and with mouse ESCs attached to immobilized fragment as in the adhesion assay (i.e., assuming that the fragment acts as part of a modified ECM). Developmental EMT can be monitored by following the expression of E-cadherin, N-cadherin, snai1 (snail), snai2 (slug), and MMP9. As expected for ESCs undergoing EMT, E-cadherin is down-regulated, and N-cadherin, MMP2, MMP9, snai1, and snai2 are up-regulated in our cells (Fig. S3A) . The expression of the same genes, but with β1-LN-LE1-4 fragment added to the medium, was then evaluated. When the fragment was provided as a soluble factor, we observed no difference in the expression of N-cadherin, snai1, and snai2 in mouse ESCs after 5 d of differentiation, but there was a significant up-regulation of E-cadherin compared with the control (Fig. 4A) . The experiment was repeated using mouse and human EBs, where we could observe the same changes in E-cadherin expression for mouse EBs, but not for human EBs (Figs. S3 B and C and S4 show human ESCs during EB and monolayer differentiation). The up-regulation of E-cadherin also held true on a protein level (Fig. 4B) . Interestingly, when mouse ESCs were cultured on tissue culture plastic coated with β1-LN-LE1-4 fragment, we observed not only a significant up-regulation of E-cadherin on both the gene and protein levels, but also a significant up-regulation of MMP9 compared with cells attached to full-length laminin-111 (Fig. 4 C and D) . Additionally, snai1 and snai2, transcriptional inhibitors of E-cadherin, were significantly down-regulated. These data suggest that, in mouse ESCs, the β1-LN-LE1-4 fragment affects the EMT by the regulation of E-cadherin, MMP2, and MMP9 expression, plausibly by α3β1-integrin-dependent pathways. The effect of the β1-LN-LE1-4 fragment was even enhanced when cells were directly attached to the fragment. Notably, there was no change in EMT regulation when cells were exposed to full-length laminin-111, indicating that the released fragment had different activities from its parent molecule.
Blocking of EMMPRIN/CD147 Reverses Effect of β1-LN-LE1-4 Fragment on MMP2, MMP9, and E-Cadherin Expression in Mouse ESCs. α3β1-integrin has been linked to E-cadherin and cytoskeleton organization in a variety of cell types (25, 44) . It has also been shown that a relationship exists between E-cadherin signaling and MMP2 and MMP9 regulation in mouse embryos during implantation (23). Moreover, it has been shown that EMMPRIN (CD147) (50) can complex with α3β1-integrins (43), thereby feeding into the regulatory pathway of MMP2 and MMP9 (29, 51) . To investigate whether the observed changes in E-cadherin, MMP2, and MMP9 expression in mouse ESCs due to the β1-LN-LE1-4 fragment are mediated by the α3β1-integrin/EMMPRIN complex, EMMPRIN was blocked by using a function-blocking antibody (52) . When EMMPRIN was blocked, the β1-LN-LE1-4 fragment no longer caused an up-regulation of E-cadherin after 5 d of differentiation (Fig. 5) . Interestingly, EMMPRIN blockage also impacted the regulation of MMP2 and MMP9. When EMMPRIN was blocked, MMP2 was no longer down-regulated by the β1-LN-LE1-4 fragment but, rather, significantly upregulated. Equally, the effect on MMP9 expression was reversed by blocking EMMPRIN. In contrast, N-cadherin, snai1, and snai2 expression were not affected by blocking of EMMPRIN. The collective data suggest that the laminin β1-LN-LE1-4 fragment acts via the α3β1-integrin/EMMPRIN complex to regulate the expression of MMP2, MMP9, and E-cadherin.
Discussion
Understanding the dynamic interactions between the ECM and cells is necessary to successfully model different phases of development in vitro. Indeed, most paracrine and autocrine signaling processes are triggered or modulated by changes within ECM components. Laminin-111 is one of the first ECM proteins expressed during embryonic development, and its relevance and importance in the assembly and stability of the basement membrane has been demonstrated in a variety of different studies over the past decade (3, 53) . It is because of radical changes in the structure of the basement membrane that cells are allowed to migrate within the early embryo, differentiate into different cell types, and ultimately form different districts and organs from an originally unspecialized homogeneous pool of progenitors. At the onset of these events, the EMT represents one of the most important processes that the field is still seeking to fully understand, and our results suggest that this process is tightly linked to the state of the early ECM by a feedback mechanism. The multifunctionality of laminins has been shown by unveiling the role of single domains of the protein spanning from basement membrane assembly (32) to cell adhesion (54) to maintaining pluripotency (35, 36) . Here, we report a biological activity of a laminin fragment, β1-LN-LE1-4, that is released through MMP2 processing and that goes beyond cell adhesion and migration. We show that the fragment interacts with mouse ESCs in an α3β1-integrin-dependent fashion, thereby enabling ESCs to adhere in a similar way as to full-length laminin-111. The β1-LN-LE1-4 fragment triggers the down-regulation of MMP2 in human and mouse ESCs, as well as the up-regulation of E-cadherin and MMP9 in mouse ESCs during spontaneous differentiation. Interestingly, the fragment acts on EMT genes in a similar way when added to the medium as a soluble factor and when cells are directly attached to it. Apparently, the β1-LN-LE1-4 fragment can only exhibit its biological function once cleaved from laminin-111, because when cells are attached to full-length laminin-111, the EMT is not affected at all. Thus, the release of the β1-LN-LE1-4 fragment appears to be required for this particular biological activity. These data show a clear link between laminin-111 and pathways relevant in the EMT. The down-regulation of MMP2 seems to be a feedback mechanism that is conserved in both human and mouse cells. One can imagine this fragment as an indicator for the amount of basement membrane that is cleaved by MMP2. Once a certain amount of laminin has undergone cleavage, MMP2 is down-regulated, and the rate of basement membrane degradation is decreased. This result was observed for both human and mouse ESCs. In mouse ESCs, the β1-LN-LE1-4 fragment also has a significant impact on the expression of EMTrelevant proteins. It causes a significant up-regulation of E-cadherin and MMP9 during differentiation of mouse ESCs. α3β1-integrin has been suggested to be linked to E-cadherin function. These data provide strong evidence that the interaction of the fragment with α3β1-integrin is linked to the regulation of MMP2, MMP9, and E-cadherin. It is also shown that this link is provided by the type I transmembrane glycoprotein EMMPRIN (CD147). EMMPRIN was blocked in mouse ESCs by using a functionblocking antibody (52) . The blocking of EMMPRIN affects the signaling elicited by the β1-LN-LE1-4 fragment, reversing its effect. Hence, it can be concluded that one possible link between α3β1-integrin and the regulation of MMP2, MMP9, and Ecadherin is established by the interaction with EMMPRIN. To our knowledge, here we show for the first time that there is a link between the processing of laminin-111 and the regulation of MMP2 during spontaneous differentiation of human and mouse ESCs. Re-creating the different cellular components that are involved in the phases of development-particularly at the pluripotent stage and the early embryonic development-has granted and will continue to grant invaluable insights for both fundamental studies and when developing new applications and disease-modeling platforms. It is also important to consider, however, that these developmental processes take place in the context of a complex and dynamic cross-talk between the cells and the ECM, which first needs to be understood and ultimately incorporated into those in vitro models. Understanding the role of MMP-ECM interactions in stem cell differentiation will lead to a more precise use of the ECM in possible applications and a deeper knowledge of the early onset of embryonic development.
Materials and Methods
Details of mouse D3 and human H9 embryonic stem cell culture techniques, cleavage of laminin-111, western blots, mass spectrometry sample preparation, NanoLC-MS/MS, EMMPRIN blocking, quantitative PCR and primer sequences, cell adhesion and integrin assay, fluorescent labeling and confocal microscopy, immunogold/SEM, and MMP2 activity are available in SI Materials and Methods.
